PF-03654746 Tosylate
Cat.No:IP5720 Solarbio
CAS:1039399-17-1
Molecular Formula:C25H32F2N2O4S
Molecular Weight:494.59
Storage:Powder:2-8℃,2 years
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
GPCR & G Protein >
PF-03654746 TosylateCAS:1039399-17-1
Molecular Formula:C25H32F2N2O4S
Molecular Weight:494.59
Storage:Powder:2-8℃,2 years
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 1039399-17-1 |
Name | PF-03654746 Tosylate |
Molecular Formula | C25H32F2N2O4S |
Molecular Weight | 494.59 |
Solubility | Soluble in Water ≥0.5mg/mL(Need ultrasonic) |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years |
SMILES | CCNC(=O)C1CC(C1)(C2=CC(=C(C=C2)CN3CCCC3)F)F.CC1=CC=C(C=C1)S(=O)(=O)O |
InChIKey | IKAYTZLLIWAEDV-UHFFFAOYSA-N |
InChI | InChI=1S/C18H24F2N2O.C7H8O3S/c1-2-21-17(23)14-10-18(20,11-14)15-6-5-13(16(19)9-15)12-22-7-3-4-8-22;1-6-2-4-7(5-3-6)11(8,9)10/h5-6,9,14H,2-4,7-8,10-12H2,1H3,(H,21,23);2-5H,1H3,(H,8,9,10) |
PubChem CID | 24862242 |
Target Point | Histamine Receptor |
Passage | GPCR & G Protein;Neuronal Signaling;Immunology & Inflammation |
Background | PF-03654746 Tosylate is a potent and selective histamine H3 receptor antagonist with high brain penetration. PF-03654746 Tosylate reduces allergen-induced nasal symptoms[1]. PF-03654746 Tosylate has potential for treatment of human cognitive disorders, improves cognitive efficacy and disease-modifying effects in Alzheimers disease (AD)[2]. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.